Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares
AI-generated summary
Officer Jason Pitofsky proposed to sell 3,883 shares of common stock with an aggregate market value of $3,789,808 through UBS Financial Services Inc. The shares were originally acquired through stock option grants on December 9, 2020, December 8, 2021, and December 16, 2022. The sale was scheduled for November 4, 2026.
Key facts
- Seller
- Jason Pitofsky
- Relationship
- Officer
- Shares to sell
- 3,883
- Market value
- $3,789,808.00
- Approximate sale date
- Nov 4, 2026
- Broker
- UBS Financial Services Inc
- Acquired (1)
- Dec 9, 2020 · stock option grant
- Acquired (2)
- Dec 8, 2021 · stock option grant
- Acquired (3)
- Dec 16, 2022 · stock option grant
More REGN filings
- 144
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 3, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.